Viridian Therapeutics Inc (0K1R)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -147.707 | -93.451 | -55.135 | -86.865 | -137.094 | -47.416 | -40.662 | -51.373 |
Return on Equity (%) | -251.369 | -138.864 | -72.791 | -124.811 | 491.957 | -125.107 | -44.571 | -56.8 |
Return on Invested Capital (%) | -232.615 | -110.421 | -61.449 | -105.767 | -158.521 | -52.211 | -45.92 | -59.15 |
Operating Margin (%) | -376.955 | -652.735 | -379.561 | -919.928 | -10495.905 | -2680.054 | -7301.806 | -75123.248 |
Net Profit Margin (%) | -379.802 | -662.303 | -389.971 | -938.646 | -10544.286 | -2680.155 | -7329.233 | -75711.465 |
Book Value Per Share | -0.439 | 1.706 | 1.665 | 0.452 | 28.371 | 2.252 | 6.123 | 4.452 |
Earnings Per Share | -17.081 | -1.175 | -1.06 | -1.201 | -26.168 | -3.319 | -3.144 | -4.494 |
Cash Per Share | 4.503 | 2.102 | 1.057 | 0.713 | 10.848 | 1.768 | 3.766 | 1.944 |
Working Capital Per Share | -0.439 | 2.126 | 1.901 | 0.561 | 28.111 | 7.797 | 9.631 | 8.692 |
Operating Profit Per Share | 1.318 | 0.177 | 0.272 | 0.128 | 0.248 | 0.124 | 0.043 | 0.006 |
EBIT Per Share | -17.081 | -1.175 | -1.06 | -1.201 | -26.168 | -3.319 | -3.144 | -4.494 |
EBITDA Per Share | -17.081 | -1.175 | -1.06 | -1.201 | -26.168 | -3.319 | -3.144 | -4.494 |
Free Cash Flow Per Share | -17.332 | -1.178 | -1.055 | -1.207 | -26.214 | -3.31 | -3.131 | -4.487 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 742k | 22,57M | 30,84M | 34,86M | 4,23M | 23,92M | 41,31M | N/A |
Capitalisation boursière | 393,34M |
Ratio cours/bénéfice | -4,24 |
Ratio prix/ventes | 3,19k |
Ratio prix/liquidités | 9,79 |
Ratio prix/valeur comptable | 2,28 |
Rendement de dividende | - |
Actions en circulation | 52,59M |
Volume moyen (1 semaine) | 755 |
Volume moyen (1 mois) | 2,49k |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 7,48 |
Plus bas sur 52 semaines | 7,48 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales